Jim Cramer: Lemonade Is 'Up Too Much,' This Health Care Stock Can Go Lower (UPDATED) JMP Securities analyst Ronald Josey maintained Lemonade with a Market Outperform and raised the price target ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback